Literature DB >> 28332275

Thyroid dysfunction in patients with Down syndrome: Results from a multi-institutional registry study.

Jenifer Lavigne1, Christianne Sharr2, Ibrahim Elsharkawi2, Al Ozonoff3,4, Nicole Baumer3,5, Campbell Brasington1, Sheila Cannon6, Blythe Crissman7, Emily Davidson3,5, Jose C Florez2,3, Priya Kishnani7, Angela Lombardo5, Jordan Lyerly1, Mary Ellen McDonough2, Alison Schwartz2,3, Kathryn Berrier7, Susan Sparks1, Kara Stock-Guild5, Tomi L Toler2, Kishore Vellody6, Lauren Voelz5, Brian G Skotko2,3.   

Abstract

The goals of this undertaking were to assess the outcomes of thyroid screening tests and adherence to thyroid screening guidelines across five Down syndrome (DS) specialty clinics in various states. Data related to thyroid screening were collected for 663 individuals across five clinics specializing in the comprehensive care of individuals with DS for a period of 1 year. Of the 663 participants, 47.7% of participants had a TSH and free T4 ordered at their DS specialty clinic visit. Approximately 19.0% (60/316) had a new thyroid disorder diagnosis made. We conclude that a sizable proportion of the patients with DS are not up-to-date on current guidelines when they present to a DS specialty clinic, while adherence to thyroid screening guidelines helps facilitate early diagnoses. Hypothyroidism is prevalent in the population, consistent with reported literature. DS specialty clinics can help patients stay current on screening guidelines.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  Down syndrome; patient database; registry; subclinical hypothyroidism; thyroid disease; trisomy 21

Mesh:

Substances:

Year:  2017        PMID: 28332275     DOI: 10.1002/ajmg.a.38219

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  6 in total

1.  Three Copies of Four Interferon Receptor Genes Underlie a Mild Type I Interferonopathy in Down Syndrome.

Authors:  Xiao-Fei Kong; Lisa Worley; Darawan Rinchai; Vincent Bondet; Puthen Veettil Jithesh; Marie Goulet; Emilie Nonnotte; Anne Sophie Rebillat; Martine Conte; Clotilde Mircher; Nicolas Gürtler; Luyan Liu; Mélanie Migaud; Mohammed Elanbari; Tanwir Habib; Cindy S Ma; Jacinta Bustamante; Laurent Abel; Aimé Ravel; Stanislas Lyonnet; Arnold Munnich; Darragh Duffy; Damien Chaussabel; Jean-Laurent Casanova; Stuart G Tangye; Stéphanie Boisson-Dupuis; Anne Puel
Journal:  J Clin Immunol       Date:  2020-06-22       Impact factor: 8.317

2.  Prevalence of Common Disease Conditions in a Large Cohort of Individuals With Down Syndrome in the United States.

Authors:  Brian Chicoine; Anne Rivelli; Veronica Fitzpatrick; Laura Chicoine; Gengjie Jia; Andrey Rzhetsky
Journal:  J Patient Cent Res Rev       Date:  2021-04-19

3.  Prevalence of Endocrine Disorders Among 6078 Individuals With Down Syndrome in the United States.

Authors:  Anne Rivelli; Veronica Fitzpatrick; Danielle Wales; Laura Chicoine; Gengjie Jia; Andrey Rzhetsky; Brian Chicoine
Journal:  J Patient Cent Res Rev       Date:  2022-01-17

4.  Down syndrome with primary thyroid diffuse large B-cell lymphoma and Hashimoto thyroiditis: A CARE compliant case report.

Authors:  Luyang Wei; Ning Zhao; Yalun Li; Xiaodan Zheng; Huaxin Zhang; Zhongtao Zhang
Journal:  Medicine (Baltimore)       Date:  2019-08       Impact factor: 1.817

Review 5.  Autoimmunity and Genetic Syndromes: A Focus on Down Syndrome.

Authors:  Marta Ferrari; Stefano Stagi
Journal:  Genes (Basel)       Date:  2021-02-13       Impact factor: 4.096

Review 6.  Down Syndrome Is a Metabolic Disease: Altered Insulin Signaling Mediates Peripheral and Brain Dysfunctions.

Authors:  Mara Dierssen; Marta Fructuoso; María Martínez de Lagrán; Marzia Perluigi; Eugenio Barone
Journal:  Front Neurosci       Date:  2020-07-08       Impact factor: 4.677

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.